iSpecimen
ISPC
8 hedge funds and large institutions have $152K invested in iSpecimen in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
82% more capital invested
Capital invested by funds: $83.5K → $152K (+$68.5K)
5.44% less ownership
Funds ownership: 5.44% → 0% (-5.4%)
11% less funds holding
Funds holding: 9 → 8 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$127K |
| 2 |
Jane Street
New York
|
+$95.2K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
+$33.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$219 |
| 5 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$49.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.92K |
| 3 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$4.42K |
| 4 |
SG
StoneX Group
New York
|
-$3.09K |
| 5 |
GCP
Gill Capital Partners
Denver,
Colorado
|
-$2 |
ISPC Hedge Fund Activity: Q2 2026 in Review
8 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2026, worth a combined $152K — up 82% from $83.5K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ISPC and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, adding an estimated $127K. The largest seller was Geode Capital Management, exiting entirely with an estimated $49.2K sold.
- 8 institutional investors held iSpecimen (ISPC) as of Q2 2026, down from 9 in Q1 2026.
- Funds reported $152K of iSpecimen stock for Q2 2026, up 82% quarter-over-quarter.
- 3 funds opened new iSpecimen positions in Q2 2026 and 4 closed out, a net change of -1 holder.
- The largest iSpecimen buyer in Q2 2026 was UBS Group, an estimated $127K added.
- The largest iSpecimen seller in Q2 2026 was Geode Capital Management, an estimated $49.2K sold.
Based on aggregated 13F filings for Q2 2026.